https://www.pharmaceutical-technology.com/news/takeda-anaemia-therapy-keros/ 2024-12-04T08:32:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/all-in-one-milling-platforms-how-to-reduce-your-machinery-footprint/ 2024-12-05T10:28:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-2-0-could-see-a-rise-in-biopharmaceutical-ma-deals/ 2024-12-03T17:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cobenfy-emraclidine-muscarinic-path/ 2024-12-03T16:18:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-acquires-longboard-pharmaceuticals/ 2024-12-03T14:04:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-olema-alliance-250m-breast-cancer-trials/ 2024-12-03T13:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/turkiye-pharmaceutical-euro-exchange-rate/ 2024-12-03T12:02:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-tremfya-sblas-paediatric/ 2024-12-03T10:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-ptc-partner-huntingtons/ 2024-12-03T08:42:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/faron-pharma-secures-uk-innovation-passport-for-blood-cancer-immunotherapy/ 2024-12-02T17:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fate-bob-valamehr-ceo/ 2024-12-02T13:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-recommends-oral-peanut-allergy-immunotherapy-treatment-for-toddlers/ 2024-12-02T11:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/meet-the-company-on-a-mission-to-reengineer-drug-development/ 2024-12-03T16:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cbc-ucb-business-china/ 2024-12-02T10:39:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uq-skin-cancer-cream/ 2024-12-02T08:07:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/prep-therapies-utter-new-hope-in-hiv-preventive-landscape-as-vaccine-failures-amass/ 2025-05-01T08:12:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-launches-esmp-for-better-management-of-drug-shortages-in-eu/ 2024-11-29T17:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-birmingham-gvhd/ 2024-11-29T14:05:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-to-launch-first-ever-mens-health-strategy/ 2024-11-29T12:27:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-reports-near-eradication-of-meningitis-c-amid-declining-vaccine-uptake/ 2024-11-29T11:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cpis-medicines-manufacturing-innovation-centre-takes-delivery-of-pace-just-in-time-jit-clinical-trials-drug-dispensing-system/ 2024-12-06T15:59:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allink-adc-pipeline/ 2024-12-02T14:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formosa-medvisis-eye-therapy/ 2024-11-29T08:33:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trump-2-0-spells-global-change-in-pharmaceutical-regulation-funding-and-investment/ 2024-11-28T16:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advanz-liver-disease-drug-european-market-after-court-hearing/ 2024-11-28T15:51:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kronos-ceo-lay-workforce/ 2024-11-28T15:50:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-agency-nominations-pharma-divided/ 2024-11-29T17:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-wegovy-non-fatal-mi/ 2024-11-28T11:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/combatting-infectious-disease-challenges-and-opportunities-for-pharma-in-the-green-transition/ 2024-11-28T11:18:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cervomeds-stock-rises-as-fda-grants-orphan-drug-status-to-dementia-drug/ 2024-11-28T11:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galactosemia-therapy-fda-shuns-applied-therapeutics-govorestat/ 2024-11-28T11:03:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-gsk-menveo-imd/ 2024-11-28T08:33:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asthma-treatment-biologic-revolution/ 2024-11-27T16:28:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigenes-pd-1-drug-approved-in-eu-for-first-line-oesophageal-cancer-treatment/ 2024-11-27T16:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oral-glp-1r-therapies-obesity/ 2024-11-27T16:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outlook-therapeutics-stock-craters-as-the-wet-amd-drug-fails-phase-iii-trial/ 2024-11-27T15:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/digital-transformation-expected-to-shorten-drug-development-timelines/ 2024-11-27T14:47:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-novartis-kisqali-breast/ 2024-11-27T14:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approval-medtronic-inpen-app/ 2024-11-27T12:54:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idorsia-plans-further-job-cuts-and-asset-sale-in-latest-cost-saving-measures/ 2024-11-27T12:48:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-decision-of-solenos-prader-willi-syndrome-drug/ 2024-11-27T11:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-agreement-saniona-san711/ 2024-11-27T11:06:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrowhead-sarepta-genetic-diseases/ 2024-11-27T08:33:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-rolls-out-monoclonal-antibody-treatment-for-rare-bone-disease/ 2024-11-26T15:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eton-rights-diabetes-ammtek/ 2024-11-26T13:48:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-tiragolumab-flops-in-another-phase-iii-lung-cancer-trial/ 2024-11-26T12:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-adds-investigational-hiv-vaccine-to-its-portfolio-from-spanish-biotech/ 2024-11-26T11:43:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-to-acquire-poseida/ 2024-11-26T10:19:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-shorla-imkeldi/ 2024-11-26T08:21:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-pci-pharma-services/ 2025-01-22T07:43:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-raises-135m-as-adc-funding-frenzy-continues/ 2024-12-02T14:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/sustainability-in-biopharma-collaboration-and-technology-light-the-way-forward/ 2024-12-10T10:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-japan-extended-rsv/ 2024-11-25T14:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-boom-bust-biopharmaceutical-deal-activity/ 2024-11-25T12:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-eyes-up-combo-approval-for-previously-withdrawn-myeloma-drug/ 2024-11-25T12:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-msds-welireg-vhl/ 2024-11-25T11:18:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/exploring-drug-shortages-european-markets/ 2024-11-25T12:31:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bridgebios-attruby-attr-cm/ 2024-11-25T08:38:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uk-point-of-care-production-cell-therapies/ 2024-11-22T16:41:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-eyes-fda-approval-for-injection-based-tremfya-in-ulcerative-colitis/ 2024-11-22T16:26:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/no-magic-wand-for-novo-nordisk-as-cagrisema-pen-supply-rumours-swirl/ 2024-11-25T10:19:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-jj-carvykti/ 2024-11-22T15:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/europe-tcr-immunotherapy-licensing-deals/ 2024-11-22T12:02:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enveda-raises-130m-to-advance-ai-driven-plant-based-drug-development/ 2024-11-22T11:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneal-files-again-for-fda-approval-of-first-dihydroergotamine-autoinjector/ 2024-11-22T11:34:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zai-pfizer-xacduro-china/ 2024-11-22T10:36:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-pharma-green-shift-with-dry-powder-inhalers/ 2024-11-22T10:07:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquires-kate-therapeutics/ 2024-11-22T08:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-oz-nominated-to-lead-cms-despite-big-pharma-ties/ 2024-11-22T09:49:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-marks-says-rfk-jr-dialogue-gives-chance-to-have-lies-debunked-on-vaccines/ 2024-11-22T09:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-apis-can-unlock-automation-and-efficiencies-across-eclinical-technologies/ 2024-11-21T17:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/worldwide-2024-elections-pose-pivotal-shifts-in-life-sciences-and-healthcare/ 2024-11-21T16:25:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-biologics-inks-668m-manufacturing-deal-with-european-pharma/ 2024-12-02T14:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genprex-university-of-michigan-lung/ 2024-11-21T14:17:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-alloy-therapeutics-car-t-therapies/ 2024-11-21T12:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kura-kyowa-kirin-aml/ 2024-11-21T10:37:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-pfizer-hympavzi-haemophilia/ 2024-11-21T08:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-life-science-startups-have-trouble-scaling-up-says-lord-vallance/ 2024-11-20T16:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/km-biologics-mpox-vaccine-approved-for-emergency-use-by-who/ 2024-11-20T14:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tris-ex-us-adhd/ 2024-11-20T14:28:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veeva-commercial-summit-increased-investment-in-medical-affairs-by-pharma-companies-2/ 2024-11-20T13:20:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parkinsons-disease-cases-to-reach-3-15-million-in-7mm-by-2033/ 2024-11-20T12:28:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmanovia-lindis-catumaxomab/ 2024-11-20T11:35:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wes-streeting-says-patients-should-view-data-sharing-the-same-as-taxes/ 2024-11-20T11:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazeneca-enhertu-snubbed-uk-nice/ 2024-12-02T14:15:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2024-phase-iii-brooklyn-trial-obicetrapib-hefh-patients/ 2024-11-20T11:13:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-crl-astellas-izervay/ 2024-11-20T08:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-shares-additional-draft-guidance-on-cgts/ 2024-11-19T17:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regenxbio-eyes-2026-filing-for-duchenne-muscular-dystrophy-gene-therapy/ 2024-11-20T10:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aclaris-rights-biosion/ 2024-11-19T15:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-cfo-backs-resilient-pharma-industry-amid-rfks-impending-governance/ 2024-11-25T12:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/does-southeast-asia-have-a-growing-role-in-vaccine-development/ 2024-12-18T11:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2024-glp-1ra-empagliflozin-therapy-t2d/ 2024-11-19T12:09:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-strengthens-radiopharma-leadership-with-ratio-therapeutics-deal/ 2024-11-19T11:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recode-funds-cystic-fibrosis/ 2024-11-19T10:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2024-tirzepatide-heart-failure-hfpef-obesity/ 2024-11-19T12:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-astrazenecas-tagrisso-nsclc/ 2024-11-19T08:06:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-picks-first-treg-cell-therapy-from-quell-therapeutics-partnership/ 2024-11-26T15:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intellias-gene-editing-therapy-shows-early-potential-in-rare-heart-condition/ 2024-11-18T14:31:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-sandozs-afqlir-retinal/ 2024-11-18T14:04:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-elahere-wins-european-approval-for-certain-ovarian-cancers/ 2024-11-20T09:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-syndaxs-revuforj/ 2024-11-18T10:40:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/plozasiran-phase-iii-fcs-adults/ 2024-11-18T16:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2024-lerodalciep-trial-liberate-ole/ 2024-11-21T13:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-recommends-bms-opdivo/ 2024-11-18T08:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-reviews-sanofi-and-regenerons-dupixent-label-expansion-for-urticaria/ 2024-11-18T16:03:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ac-immune-parkinsons-disease-trial-therapy-benefit/ 2024-11-15T16:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-azurity-danziten-cml/ 2024-11-15T15:31:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-shares-sink-by-12-after-mpox-sales-slump-in-q3/ 2024-11-15T14:29:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-lanovas-lm-299/ 2024-11-20T09:34:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-chmp-sanofis-sarclisa/ 2024-11-15T08:36:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-picks-vaccine-sceptic-rfk-jr-to-lead-hhs-in-new-administration/ 2024-11-15T14:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-rethinks-stance-committee-now-recommends-leqembi-for-alzheimers-disease/ 2024-11-14T21:05:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kronos-mulls-strategic-alternatives-after-axing-cancer-drug-development/ 2024-11-14T17:24:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adaptimmune-nears-second-sarcoma-approval-as-phase-ii-trial-hits-endpoints/ 2024-11-14T15:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/metsera-raises-215m-in-series-b-round-for-weight-loss-candidates/ 2024-11-14T15:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ptcs-gene-therapy/ 2024-11-14T14:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/huaweis-top-10-construction-principles-for-intelligent-computing-centre-facilities/ 2025-07-21T13:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valo-health-brian-alexander-ceo/ 2024-11-14T10:26:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/perceptive-eclinical-launches-clinphone-5/ 2024-12-16T14:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-agreement-acquire-biotheus/ 2024-11-18T09:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syndaxs-stock-sinks-by-25-despite-aml-trial-meeting-primary-endpoint/ 2024-11-13T17:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-development-of-novel-drugs-the-role-of-lyophilization/ 2024-11-14T13:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intercept-loses-ocaliva-fda-full-approval-bid-in-rare-liver-disease/ 2024-11-13T15:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-gsks-ojjaara/ 2024-11-13T13:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syros-stock-craters-after-lead-cancer-therapy-flops-in-phase-iii-trial-2/ 2024-11-13T15:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ontada-datavant-oncology-data/ 2024-11-13T10:40:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-divestiture-hospital-business/ 2024-11-13T08:37:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clears-novavax-to-resume-trials-of-covid-19-and-flu-combo-vaccine/ 2024-11-12T16:53:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-launches-game-changer-and-lifesaving-anti-smoking-pill/ 2024-11-12T16:43:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-dry-powder-inhalers-the-key-to-sustainable-respiratory-care/ 2024-11-14T10:47:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dmts-are-major-clinical-research-focus-for-parkinsons-disease-analysis-shows/ 2024-11-12T15:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uppsala-kth-antibody-cancer/ 2024-11-12T14:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/idweek-2024-strategic-approaches-challenges-mpox-vaccination/ 2024-11-12T13:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zai-argenx-nmpa-vyvgart/ 2024-11-12T11:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-btd-nipocalimab-sjd/ 2024-11-12T08:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-bostongene/ 2024-11-12T05:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-2-0-spells-uncertainty-for-us-healthcare-says-analyst/ 2024-11-12T17:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/autolus-secures-fda-approval-for-car-t-cell-therapy-use-in-all/ 2024-11-13T14:00:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-priority-review-of-neurotechs-eye-cell-therapy-implant/ 2024-11-11T16:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/gamma-delta-t-cells-explained-the-next-medical-breakthrough/ 2024-11-11T15:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alk-snags-eu-and-canada-rights-to-anaphylaxis-nasal-spray-neffy-for-145m/ 2024-11-11T15:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allovir-kalaris-merger-retinal/ 2024-11-11T14:44:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-to-adapt-to-choppy-waters-in-biotech-ecosystem/ 2024-11-11T13:05:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-mresvia-health-canada/ 2024-11-11T10:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dizal-fda-nsclc-sunvozertinib/ 2024-11-11T08:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/investment-surges-hurdles-and-emerging-innovations-in-neuroscience/ 2024-11-09T00:04:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ultra-processed-food-boom-obesity-drug-ozempic/ 2024-11-08T17:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-lowers-leqembi-revenue-forecast-after-rocky-entry-to-market/ 2024-11-11T14:03:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharma-cold-chains-major-trends-shaping-the-next-decade/ 2024-11-13T14:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aurinia-slashes-workforce-by-45-to-focus-on-lupus-and-autoimmune-assets/ 2024-11-08T14:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lakeshore-bla-drap-rabies/ 2024-11-08T14:22:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-and-amgens-tezspire-succeeds-in-phase-iii-nasal-polyps-trial/ 2024-11-08T13:53:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-fundamentals-of-developing-parenteral-drug-products/ 2025-07-03T10:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mustang-mb-108-fda/ 2024-11-08T10:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sonnet-secures-us-patent/ 2024-11-08T10:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santen-arctic-deal-arvn001/ 2024-11-08T09:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/canada-privateequity-activity-pharmaceutical-industry/ 2024-12-02T16:27:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/privateequity-activity-artificial-intelligence-pharmaceutical-industry/ 2024-11-08T03:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/ma-activity-ecommerce-pharmaceutical-industry/ 2024-12-02T16:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/privateequity-activity-covid-19-pharmaceutical-industry/ 2024-11-08T03:42:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/minister-for-science-champions-partnerships-with-private-clinical-sector-in-uk/ 2024-11-07T17:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dbv-technologies-stock-slides-as-financial-woes-worsens/ 2024-11-07T16:08:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vidac-secures-funding-to-advance-skin-cancer-trials-of-novel-ointment/ 2024-11-07T16:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-people-first-approach-transforming-eclinical-processes/ 2025-05-27T16:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-global-drug-regulations-are-evolving/ 2024-11-11T10:04:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gho-ampersand-capital-avid/ 2024-11-07T11:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-dupixent-young-eoe/ 2024-11-07T08:28:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deepmind-nobel-prize-winner-says-ai-will-have-electricity-type-of-impact/ 2024-11-21T17:48:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zentiva-voices-uwwtd-concerns-as-eu-grants-approval/ 2024-11-06T18:03:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intra-cellular-bolsters-caplyta-data-with-another-phase-iii-win/ 2024-11-06T17:07:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-market-cap-q3/ 2024-11-06T16:27:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/strong-wegovy-revenue-growth-for-novo-nordisk-but-shares-dip/ 2024-11-06T16:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cervical-cancer-navigating-todays-global-clinical-trial-landscape/ 2024-11-11T13:36:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-ceo-addresses-declining-trust-in-vaccines-following-trump-re-election/ 2024-11-06T14:56:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tevogen-bio-microsoft-hpv/ 2024-11-06T14:45:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-wins-election-2024-healthcare-what-means/ 2024-11-06T11:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nxera-partners-antiverse-gpcrs/ 2024-11-06T11:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-vaccine-canada-50-59/ 2024-11-06T08:31:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-shares-up-after-full-year-product-revenue-guidance-boost/ 2024-11-05T17:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nls-and-kadimastem-stocks-soar-following-merger-agreement/ 2024-11-05T16:53:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-285m-deal-with-ascendis-to-create-once-monthly-glp-1ra/ 2024-11-05T16:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-journey-medicals-rosacea-treatment-emrosi/ 2024-11-05T15:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nektar-sell-facility-ampersand/ 2024-11-05T14:34:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-nanopore-and-uk-to-develop-pathogen-surveillance-system/ 2024-11-05T14:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-alvotech-advanz-maa/ 2024-11-05T11:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-hybrid-models-and-tech-are-shaping-the-future-of-clinical-research/ 2024-11-05T11:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syndax-agreement-royalty-pharma/ 2024-11-05T08:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/injectables-manufacturing-ushers-in-a-new-era-of-accessibility/ 2024-11-04T19:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disc-teases-potential-nda-for-rare-skin-disorder-drug/ 2024-11-04T17:48:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-election-senate-president-hold-power/ 2024-11-04T16:25:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prokarium-ip-us-patents/ 2024-11-04T14:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-feliqs-flq-101-rop/ 2024-11-04T11:02:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northwestern-case-western-reserve-huntingtons-therapy/ 2024-11-04T08:05:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lexicon-stock-tumbles-after-fda-adcom-votes-against-zynquista-again/ 2024-11-01T17:07:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nccn-visits-vietnam-in-continued-cancer-care-collaboration/ 2024-11-01T17:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verastem-submits-nda-ovarian-cancer-treatment/ 2024-11-01T15:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-court-upholds-avadels-narcolepsy-drug-approval-amid-exclusivity-battle/ 2024-11-01T14:41:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-evolveimmune-therapeutics-sign-oncology-collaboration/ 2024-11-01T10:47:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-fines-teva-502m-copaxone-practices/ 2024-11-01T09:40:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/matinas-biopharma-mulls-wind-down-as-antifungal-therapy-deal-falls-through/ 2024-10-31T17:06:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-earns-higher-revenues-in-q3-2024-puts-rare-diseases-in-the-spotlight/ 2024-10-31T16:51:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reeves-2024-budget-promises-life-sciences-investment/ 2024-10-31T14:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/psoriasis-biosimilars-and-pricing-changes-herald-treatment-paradigm-disruptions/ 2024-10-30T16:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roche-dyno-therapeutics-gene-therapies-neuro-disorders/ 2024-10-30T17:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bladder-cancer-diagnoses-to-top-300000-in-major-markets-by-2033/ 2024-10-30T16:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-neomorph-molecular-glue-degrader/ 2024-10-30T16:47:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/will-the-tide-turn-for-the-wave-of-pharma-layoffs/ 2025-05-01T08:12:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-boasts-over-30-increase-in-q3-revenues-against-previous-year/ 2024-10-30T15:34:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-companies-green-chemistry/ 2024-10-30T15:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/how-a-patient-helped-shape-a-treatment-for-rare-skin-disorder/ 2024-10-30T17:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kisunla-dosing-regime-change-reduced-aria/ 2024-10-30T13:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/idweek-2024-kalihinol-analogue-antimalarial-therapy/ 2024-10-30T11:51:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/speros-stock-slides-after-antibiotic-flops-in-phase-ii-trial/ 2024-10-30T13:22:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-scemblix-fda-approval-leukaemia/ 2024-10-30T10:46:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-chimagen-cmg1a46-autoimmune/ 2024-10-30T08:15:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrivo-targets-major-depressive-disorder-in-females-after-early-efficacy-data/ 2024-10-29T17:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organon-dermatology-portfolio-dermavant-acquisition/ 2024-10-29T15:01:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-mpox-vaccine-label-expansion-to-toddlers-starts-trial/ 2024-10-29T14:04:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-border-protection-warns-pharma-of-risks-with-incorrect-biologic-importation/ 2024-10-29T11:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-fasenra-egpa/ 2024-10-29T10:43:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/south-korean-pricing-reform-drug-reimbursement/ 2024-10-29T10:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-agreement-acquire-aliada/ 2024-10-29T08:34:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transforming-pharmaceutical-rd-the-impact-of-digital-technologies-on-drug-discovery-and-development/ 2024-10-28T17:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-is-the-pharmacy-of-the-future/ 2024-10-28T17:16:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/upfs-fuelling-alarming-rise-of-chronic-diseases-in-india/ 2024-10-28T17:40:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/preparing-for-dscsa-transition-with-tech-led-compliance/ 2024-11-14T17:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-odd-mdl-101-lama2-cmd/ 2024-10-28T14:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/redling-lasting-impact-asthma/ 2024-10-28T12:50:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eu-critical-medicines-act-overreliance-asian-manufacturers/ 2025-06-19T22:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uaes-clinical-trials-space-matures-with-experience-from-covid-19/ 2024-10-28T11:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-iterum-orlynvah-nda-uuti/ 2024-10-28T10:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/social-media-engagement-boosts-rare-disease-outreach/ 2024-10-28T10:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-acp-application-europe-amd/ 2024-10-28T08:50:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-companies-must-adapt-to-keep-pace-with-ai-developments-say-experts/ 2024-10-28T10:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/af-stroke-patients-could-benefit-from-earlier-anticoagulant-administration/ 2024-10-25T16:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leos-adbry-demonstrates-long-term-efficacy-in-atopic-dermatitis/ 2024-10-25T16:13:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-pumps-up-to-800m-for-us-manufacturing-site-upgrade/ 2024-10-25T14:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lyell-goes-all-in-on-car-t-therapies-buys-immpact-bio-and-trims-pipeline/ 2024-11-26T15:18:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-backed-agomab-raises-89m-to-advance-fibrotic-disease-treatments/ 2024-10-25T14:22:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dyno-roche-neurological-gene-therapies/ 2024-10-25T13:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-bmc-decarbonise-healthcare/ 2024-10-25T10:05:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-richter-partner-neuropsychiatric/ 2024-10-25T07:47:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-cdc-adcom-recommends-lowering-the-age-for-pneumococcal-vaccines/ 2024-10-24T16:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alpha-9-becomes-latest-radiopharma-to-secure-funds-with-175m-series-c/ 2024-10-24T16:10:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmacists-desperation-by-novo-nordisk-over-semaglutide-copycat-block/ 2024-10-28T13:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/futureproofing-supply-chains-in-an-evolving-pharmaceutical-industry/ 2024-10-25T10:51:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-modifi-biosciences/ 2024-10-24T13:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opioid-treatment-market-set-to-grow-despite-expected-slump-in-us-sale-value/ 2024-10-24T13:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transforming-cml-patient-monitoring-with-icons-innovative-rna-based-ngs-assay/ 2024-10-24T14:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-europe-how-ai-can-drive-growth-in-the-nutraceutical-space/ 2024-10-24T13:26:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-europe-strategies-to-navigate-nitrosamines-risk-evaluation/ 2024-10-24T13:24:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-conflicts-prompt-gpei-to-delay-polio-eradication-target/ 2024-10-24T11:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-supervised-machine-learning-optimizes-ai-use-in-clinical-trials/ 2025-05-27T16:39:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dpv-lumos-pharma-38m/ 2024-10-24T10:41:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/treefrog-university-of-pittsburgh-tls/ 2024-10-24T08:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/be-bio-raises-82m-to-advance-haemophilia-b-gene-therapy-to-phase-i-ii-trial/ 2024-11-26T15:25:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-kisunla-does-not-demonstrate-good-value-for-uks-nhs/ 2024-10-24T02:32:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jandjs-darzalex-combined-therapy-gains-expanded-approval-from-european-commission/ 2024-10-24T07:54:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-pfizers-rsv-vaccine-label-to-include-all-high-risk-adults/ 2024-10-23T15:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ocuphire-opus-gene-therapy/ 2024-11-26T15:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-alvotech-tevas-selarsdi/ 2024-10-23T10:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aao-2024-nma-vabysmos-eylea-hd/ 2024-10-23T09:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/voranigo-health-canada-idh-mutant-glioma/ 2024-10-23T07:42:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/a-slow-start-for-self-amplifying-mrna-vaccines/ 2024-10-24T12:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-and-msd-to-advance-once-weekly-hiv-treatment-to-phase-iii/ 2024-10-22T15:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editas-and-genevant-team-up-to-develop-gene-editing-therapies/ 2024-11-26T14:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-osteoporosis-day-fragility-fractures/ 2024-10-22T13:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mangorx-hits-back-at-eli-lillys-weight-loss-drug-copycat-claims/ 2024-12-20T11:28:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-pharma-leaders-are-approaching-digital-transformation/ 2024-11-04T14:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-clinical-trial-disruption-growing-trends-and-new-technologies/ 2024-10-25T15:05:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avacta-tempus-development-cancer/ 2024-10-22T12:39:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-astrazeneca-ionis-wainzua-attrv-pn/ 2024-10-22T10:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-plans-label-expansion-for-rybelsus-following-phase-iii-win/ 2024-10-22T13:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cambridge-university-gsk-immunology-collaboration/ 2024-10-22T07:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fishers-oncomine-gains-fda-approval-as-brain-tumor-diagnostic/ 2024-10-21T15:44:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aao-2024-nanoscope-therapeutics-vision-rp-patients/ 2024-10-22T16:26:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-17bn-sale-of-opella-to-us-investors-advances-following-government-deal/ 2025-02-19T10:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-zoryve-seborrheic-dermatitis/ 2024-10-21T13:43:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seaport-raises-225m-to-advance-portfolio-of-neuropsychiatric-prodrugs/ 2024-10-21T13:42:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunoprecise-touts-potential-of-rabbit-monoclonal-antibodies-in-oncology/ 2024-10-21T13:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrobiologics-charles-river-therapies/ 2024-11-26T14:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-clamps-partial-hold-on-phase-iii-trial-of-biontech-oncoc4s-nsclc-therapy/ 2024-10-21T12:17:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astellas-vyloy-gastric-cancer/ 2024-10-21T08:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aao-2024-eyepoints-eyp-1901-proves-non-inferiority-to-aflibercept-in-davio-2/ 2024-10-22T16:25:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intercepts-liver-disease-drug-ocaliva-faces-fda-approval-delay/ 2024-10-18T23:35:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-mulls-2025-26-launch-for-rsv-vaccine-after-phase-ii-iii-win-2/ 2024-10-18T19:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avadel-wins-fda-approval-for-narcolepsy-drug-lumryz-in-children/ 2024-10-18T19:35:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mrna-licensing-agreements-surge-800-amid-gsk-lawsuits/ 2024-10-24T12:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theracosbio-bamco-brenzavvy-sub-saharan-africa/ 2024-10-18T13:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/unresolved-clawback-issues-greece/ 2024-10-18T10:06:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-orano-radioligand-therapy/ 2024-10-18T10:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/opioid-addiction-8mm-2033/ 2024-10-18T09:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sectors/healthcare/us-election-harris-trump-healthcare-policies/ 2024-10-30T12:21:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvies-vyalev-advanced-parkinsons/ 2024-10-18T08:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sage-lays-off-55-of-rd-workforce-and-refocuses-pipeline/ 2024-10-17T18:57:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordics-mpox-vaccine-equally-effective-in-teens-as-adults/ 2024-10-18T08:52:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fresenius-kabi-cellular-origins-cgt/ 2024-11-26T14:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glaukos-eyes-fda-approval-for-ocular-therapy-after-phase-iii-win/ 2024-10-17T17:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-daybue-canada-rett-syndrome/ 2024-10-17T10:28:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lexicon-viatris-expansion-sotagliflozin/ 2024-10-17T08:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-trims-neuroscience-pipeline-seltorexant-in-alzheimers-disease-dropped/ 2024-10-16T19:04:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-will-build-new-way-of-doing-science-in-uk-amid-297m-pledge-to-government/ 2024-10-16T16:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bitbio-defends-european-patent-for-novel-opti-ox-technology/ 2024-10-16T15:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/radiopharm-atomvie-radioantibody-development/ 2024-10-16T13:10:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/remote-monitoring-upgrading-chronic-care-and-addiction-management-in-scotland/ 2025-06-27T14:48:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synedgen-barda-miist305/ 2024-10-16T09:25:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/copd-market-expected-grow-30-8bn-7mm-2033/ 2024-10-16T07:52:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-urogens-ugn-102-bladder-cancer/ 2024-10-16T07:48:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hanmi-and-medic-ink-cancer-biomarker-collaboration-deal/ 2024-10-15T21:00:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-touts-omvohs-superiority-over-jjs-stelara-in-crohns/ 2024-10-15T20:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-applies-for-eu-approval-of-menopause-drug-elinzanetant/ 2024-10-15T19:22:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/transgenes-stock-drops-after-phase-ii-cancer-jab-trial-misses-primary-endpoint/ 2024-10-15T20:24:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/gitex-global-2024-huawei-launches-a-series-of-industrial-digital-and-intelligent-transformation-solutions-and-flagship-products/ 2024-10-15T16:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-twins-a-new-path-to-personalised-medicine/ 2024-10-15T15:01:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-science-of-viscous-drug-product-filling-pumps-pressure-and-process-optimization/ 2025-07-03T10:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/almirall-eu-regulatory-antifungal-treatment/ 2024-10-15T12:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/parenteral-solutions-contract-manufacturing/ 2025-11-05T11:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-growing-role-of-cdmos-in-the-circular-economy/ 2024-10-16T16:29:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/oral-solid-dosage-manufacturing/ 2025-11-05T11:47:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-partners-who-foundation/ 2024-10-15T10:07:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-longboard-pharmaceuticals/ 2024-10-15T08:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentechs-evrysdi-helped-babies-with-sma-reach-rare-milestones-in-phase-ii-trial/ 2024-10-14T16:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/top-cybersecurity-pharmaceutical-companies/ 2025-11-05T11:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharma-benefit-managers-companies/ 2025-11-05T11:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enhertu-conditional-approval-china-nsclc/ 2024-10-22T09:24:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inventiva-secures-up-to-380m-for-mash-treatment-lanifibranor/ 2024-10-14T14:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-consumer-healthcare-unit-cdr/ 2024-10-14T10:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/optimising-outcome-measures-in-cognitive-drug-trials-for-schizophrenia/ 2024-10-14T16:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/could-preventative-care-save-the-future-of-the-nhs/ 2024-10-14T13:58:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-hympavzi-haemophilia/ 2024-10-14T08:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/healing-begins-with-research-promising-development-program-on-stem-cells-in-rare-diseases/ 2024-10-14T08:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cell-and-gene-therapy-approvals-drive-paradigm-change-in-manufacturing/ 2025-03-04T13:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/south-korean-company-dong-a-st-wins-fda-approval-for-stelara-biosimilar/ 2024-10-24T20:19:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-adcom-votes-in-favour-of-stealths-barth-syndrome-drug/ 2024-10-11T16:33:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/global-awareness-geographic-variation-plaque-psoriasis/ 2024-10-11T15:14:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-wins-first-line-approval-for-pi3k-inhibitor-combo-in-breast-cancer/ 2024-10-11T15:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xtalpi-ai-based-platform-janssen/ 2024-10-11T13:48:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/activist-investor-starboard-cries-foul-play-in-exec-u-turn-at-pfizer/ 2024-10-11T13:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/booster-proteasome-activator-medicines/ 2024-10-11T10:12:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keybioscience-lilly-obesity/ 2024-10-11T08:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-milan-targeting-supply-chain-bottlenecks-key-for-cell-and-gene-therapies/ 2024-11-26T14:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-europe-overcoming-the-unique-challenges-with-high-concentration-mabs/ 2024-10-11T00:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bios-skysona-led-to-seven-cases-of-blood-cancer-in-gene-therapy-trials/ 2024-11-26T14:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/paediatric-type-2-diabetes-china/ 2024-10-10T15:32:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-scores-breakthrough-status-for-anti-rejection-transplant-medication/ 2024-10-10T15:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-and-insitro-team-up-to-develop-ai-powered-sirna-metabolic-drugs/ 2025-01-20T09:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/england-sharp-rise-food-allergy/ 2024-10-10T15:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-biosafety-testing-facility/ 2024-10-11T04:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-europe-gummies-as-a-drug-delivery-system-could-improve-compliance/ 2024-10-10T11:27:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arda-secures-43m-cell-depletion/ 2024-10-10T10:00:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-emis/ 2024-10-11T08:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-circle-cancer-treatment/ 2024-10-10T07:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anima-biotechs-machine-learning-programme-reveals-new-mrna-drug-targets/ 2024-10-10T16:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-ventures-into-fibroblast-therapies-with-1-9bn-deal-with-mestag/ 2024-10-09T14:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-to-donate-20000-narcan-doses-to-fight-opioid-overdoses-ceo-says/ 2024-10-09T14:10:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-zealand-hypoglycemia-therapy/ 2024-10-09T13:19:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purespring-secures-105m-to-start-phase-i-ii-trial-of-igan-gene-therapy/ 2024-10-09T13:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/clinical-dose-companies/ 2025-11-05T11:49:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/city-therapeutics-launch-funding/ 2024-10-09T10:04:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-elafibranor-mhra-approval-pbc/ 2024-10-09T08:15:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-cell-and-gene-therapy-approvals-drive-paradigm-change-in-manufacturing/ 2024-10-08T18:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-and-medilink-to-collaborate-on-sclc-combination-therapy/ 2024-10-16T12:01:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/strategic-market-positioning-needed-for-ebglyss-to-rival-dupixent-in-atopic-dermatitis/ 2024-10-08T15:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-moma-therapeutics-partner/ 2024-10-08T13:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-puts-technology-in-the-spotlight-in-2024-25-business-plan/ 2024-10-08T10:36:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-kickstarts-two-phase-iii-trials-as-mash-therapy-wins-breakthrough-status/ 2024-10-08T10:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-healthcare-hiv-prep/ 2024-10-08T09:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-partner-commercialise-limertinib/ 2024-10-09T12:38:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neuvivo-makes-bid-to-enter-als-arena-with-immunotherapy-candidate/ 2024-10-07T16:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-starts-review-into-hair-loss-drugs-about-potential-link-to-suicidal-thoughts/ 2024-10-07T15:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncolytics-targets-accelerated-approval-for-oncolytic-virus-therapy/ 2024-10-16T11:59:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/activist-investor-starboard-forges-1bn-stake-in-pfizer-to-swing-profits/ 2024-10-07T12:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/productlife-drug-development-intiquan/ 2024-10-07T10:29:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-health-canada-illuccix-label-expansion/ 2024-10-07T10:26:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/onkure-reneo-pharmaceuticals-merger/ 2024-10-07T08:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cd7-car-t-cell-therapy-leukaemia/ 2024-10-07T08:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mrna-licensing-agreements-double-with-million-dollar-deals/ 2024-10-07T08:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/editas-trades-part-of-vertex-crispr-therapy-licencing-rights-deal-for-57m/ 2024-10-04T22:58:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-debates-sale-of-pharma-operations-as-biosecure-act-advances/ 2024-10-04T22:47:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-benefits-of-using-a-nimble-platform-from-phase-to-phase/ 2025-05-27T16:31:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lifts-clinical-hold-on-aviditys-lead-antibody-conjugate-therapy-trial/ 2024-10-04T14:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-proposes-phased-launch-for-eli-lillys-mounjaro/ 2024-10-04T12:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recordati-sanofi-antibody-enjaymo/ 2024-10-04T10:31:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-mabxience-biosimilar-candidate-oncology/ 2024-10-04T10:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-approval-opdivo-treat-nsclc/ 2024-10-04T08:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/resilience-essential-medicine-components/ 2024-10-04T08:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/a-rational-design-approach-to-rna-targeting-to-target-large-scale-screening/ 2024-10-04T08:06:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/resolution-scores-83m-to-develop-macrophage-cell-therapies/ 2024-11-26T14:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chronic-diseases-as-urgent-as-climate-change-says-novo-nordisk-cso/ 2024-10-04T12:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advancing-pharmaceutical-security-the-role-of-securtracers-in-on-dose-authentication/ 2024-10-07T14:13:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enara-bio-secures-32-5m-for-dark-antigen-cancer-therapies/ 2024-10-03T12:46:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/leading-healthcare-payers/ 2025-11-05T11:53:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunoprecise-biotheus-bispecific-antibodies-cancer/ 2024-10-03T10:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novaliq-dry-eye-disease-therapy-2/ 2024-10-03T10:32:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/switching-from-tablets-the-benefits-of-using-softgels/ 2024-10-10T14:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-agreements-hiv-prevention-drug/ 2024-10-03T08:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-drug-manufacturing-trial/ 2024-10-03T08:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/social-media-algorithms-are-driving-the-glp-1-drugs-boom/ 2024-10-07T12:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/triveni-scores-115m-to-expand-immunology-pipeline/ 2024-10-02T17:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shattuck-labs-stock-craters-following-pipeline-and-job-cuts/ 2024-10-02T15:14:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/top-cloud-companies-healthcare/ 2025-11-05T11:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/potential-for-peptides-to-replace-antibodies-in-radiopharma-says-wuxi-apptec-exec/ 2024-10-02T14:37:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exscientia-outline-robot-and-ai-use-in-drug-discovery-workflow/ 2024-10-11T19:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/loqus23-secures-43m-to-advance-huntingtons-disease-therapy/ 2024-10-02T13:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/leading-retail-pharmacies/ 2025-11-05T11:50:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/manufacturing/the-course-to-forging-long-term-manufacturing-partnerships-for-gene-therapies/ 2024-10-01T22:36:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-buys-regors-cdk-inhibitors-in-850m-deal/ 2024-10-01T16:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/washing-disinfection-sterilisation-equipment-services/ 2025-11-05T11:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/patient-adherence-solutions-companies/ 2025-11-05T11:51:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/leading-specialty-pharmacies/ 2025-11-05T11:53:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fresenius-kabi-wins-fda-approval-for-stelara-biosimilar-otulfi/ 2024-10-01T14:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/top-robotics-companies/ 2025-11-05T11:52:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascendis-growth-hormone-deficiency-therapy/ 2024-10-01T13:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/speciality-chemicals/ 2025-11-05T11:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-and-prime-ink-potential-3-5bn-deal-to-develop-t-cell-therapies/ 2024-10-02T10:10:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-contract-rapivab-influenza/ 2024-10-01T10:35:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aktis-oncology-radiopharmaceutical-pipeline/ 2024-10-01T10:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/piramal-lexington-sterile-injectables-facility/ 2024-10-16T11:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bpgbios-mitochondrial-disorder-pediatric/ 2024-10-01T08:14:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-4-drugs-in-development/ 2024-10-01T02:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mrna-covid-19-vaccines-may-boost-cancer-immunotherapy-effectiveness/ 2024-09-30T18:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-clinches-ec-approval-for-first-single-pill-pah-combo/ 2024-09-30T16:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/keytruda-opdivo-decade-review/ 2024-09-30T15:59:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/neffy-nasal-spray-game-changer-asthma-patients-epinephrine-delivery/ 2024-09-30T14:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modalis-wins-fda-rare-paediatric-designation-for-cmd-crispr-therapy/ 2024-09-30T13:50:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valerio-therapeutics-acquistion-emglev/ 2024-09-30T10:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-pharma-enstilar-nda-plaque-psoriasis/ 2024-09-30T08:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-pharmteco-production-expansion-south-korea/ 2024-09-30T08:20:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-medidata/ 2025-01-22T07:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blockchain-leaders-finesse-tech-to-find-fake-drugs/ 2024-09-26T20:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-greenlights-regenerons-dupixent-for-the-treatment-of-copd/ 2024-09-27T18:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanofi-regeneron-dupixent-copd-fda/ 2024-09-27T16:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-wins-approval-for-schizophrenia-drug-acquired-from-karuna/ 2024-09-27T15:41:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unicef-secures-one-million-mpox-vaccines-for-africa/ 2024-09-27T14:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomeas-stock-bounces-back-as-fda-lifts-clinical-hold-on-diabetes-trials/ 2024-09-27T14:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/api-chemicals/ 2025-11-05T11:56:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tempus-ai-oncology-collaboration-takeda/ 2024-09-27T10:16:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phare-bio-ai-drug-discovery-platform/ 2024-09-27T10:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/physicians-need-improved-non-opioid-treatments-oud/ 2024-09-27T10:00:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/direct-to-patient-communication-bridging-the-gap-in-medication-adherence/ 2024-10-14T14:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/purification-and-filtration/ 2025-11-05T11:57:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-tagrisso-fda-nsclc/ 2024-09-27T08:21:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-tabuk-glp-1-middle-east/ 2024-09-27T08:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/compounding-pharmacies-get-caught-in-counterfeit-controversy/ 2024-09-27T19:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2024-west-pharma/ 2025-01-22T07:45:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-opens-66-8m-new-cancer-research-facility/ 2024-09-26T14:43:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/union-plans-phase-iii-trial-for-atopic-dermatitis-after-phase-iib-win/ 2024-09-26T14:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/how-can-the-uks-labour-government-transform-health-and-care/ 2024-09-26T10:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orion-aitia-drug-discovery-partnership/ 2024-09-26T10:01:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-msd-keytruda/ 2024-09-26T09:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/askbio-belief-biomed-partner/ 2024-09-26T07:54:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-withdraws-oxbryta-scd/ 2024-09-26T07:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genespire-raises-52m-in-series-b-to-trial-paediatric-gene-therapy/ 2024-10-02T10:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/managing-temperature-sensitive-injectable-drugs-in-fill-finish-operations/ 2025-07-03T10:14:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/why-a-new-prescription-tracking-feature-on-the-nhs-app-is-important-for-pharmacists/ 2024-09-25T16:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/epigenetic-drugs-increase-series-a-venture-financing-2024/ 2024-09-25T14:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/api-biologics/ 2025-11-05T11:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharma-solid-dose-manufacturing-contract-marketing/ 2025-11-05T11:58:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/biotechnology-equipment-materials/ 2025-11-05T11:58:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-mpox-vaccine-manufacture/ 2024-09-25T10:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generate-novartis-protein-therapeutics/ 2024-09-25T09:59:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/cleanrooms-cleanroom-flooring/ 2025-11-05T11:59:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-ozempic-mounjaro-counterfeit-compounders/ 2024-09-25T09:32:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allazohealth-introduces-ai-offering/ 2024-09-25T08:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-kisunla-alzheimers/ 2024-09-25T07:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pbms-favour-high-list-prices-novo-nordisk-ceo-targets-pbms-in-us-senate-hearing/ 2024-09-24T17:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-acquires-rls-radiopharmacies-to-expand-us-manufacturing-presence/ 2024-09-24T15:42:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/iterums-oral-sulopenem-acceptance-hinges-on-antibiotic-stewardship-efforts/ 2024-09-24T14:26:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-fruzaqla-approval-japan/ 2024-09-24T10:50:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-chmp-astrazeneca-fasenra/ 2024-09-24T10:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/clinical-trial-packaging-services/ 2025-11-05T12:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/water-purification-wastewater/ 2025-11-05T12:01:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharmaceutical-packaging-companies/ 2025-11-05T12:02:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-bimzelx-fda-approval/ 2024-09-24T08:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-leo-pharma-anzupgo/ 2024-09-24T07:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyell-immunopharma-gets-grant-for-egfr-derived-polypeptides-for-improved-cell-surface-expression/ 2024-09-24T02:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/telesis-bio-gets-grant-for-methods-for-synthesizing-dna-molecules-with-defined-sequences/ 2024-09-24T02:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laurus-labs-gets-grant-for-improved-process-for-preparing-dapagliflozin-and-its-derivatives/ 2024-09-24T02:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agile-therapeutics-gets-grant-for-transdermal-drug-delivery-device-with-specific-irritation-properties/ 2024-09-24T02:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vivos-therapeutics-gets-grant-for-oral-appliance-for-jaw-development-and-sleep-apnea-relief/ 2024-09-24T02:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nykode-therapeutics-gets-grant-for-anticancer-vaccine-comprising-neoepitopes-and-polynucleotides/ 2024-09-24T02:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/premier-gets-grant-for-stable-phytonadione-compositions-for-parenteral-administration/ 2024-09-24T02:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zymeworks-gets-grant-for-heterodimer-antibody-constructs-with-preferential-heavy-light-chain-pairing/ 2024-09-24T02:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verve-therapeutics-gets-grant-for-gene-editing-compositions-to-lower-ldl-cholesterol-levels/ 2024-09-24T02:24:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acelrx-pharmaceuticals-gets-grant-for-oral-transmucosal-drug-delivery-device-and-system/ 2024-09-24T02:24:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oxford-biomedica-gets-grant-for-nucleic-acid-sequence-for-repressing-translation-in-viral-vectors/ 2024-09-24T02:24:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orion-gets-grant-for-cyp11a1-inhibitors-for-treating-prostate-cancer/ 2024-09-24T02:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/optibiotix-health-gets-grant-for-modified-prebiotic-oligosaccharides-with-increased-sweetness-value/ 2024-09-24T02:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frequency-therapeutics-gets-grant-for-oligonucleotide-compositions-for-treating-mrna-related-disorders/ 2024-09-24T02:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acorda-therapeutics-gets-grant-for-sustained-release-4-aminopyridine-tablets-for-neurological-disorders/ 2024-09-24T02:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aquestive-therapeutics-gets-grant-for-enhanced-pharmaceutical-compositions-for-active-component-permeation/ 2024-09-24T02:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocular-therapeutix-gets-grant-for-intracanalicular-injectable-applicator-device-for-drug-delivery/ 2024-09-24T02:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eiger-biopharmaceuticals-gets-grant-for-combination-treatment-for-hepatitis-delta-virus-hdv-infection/ 2024-09-24T02:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemomab-therapeutics-gets-grant-for-anti-ccl24-antibodies-for-treating-hepatic-pathologies/ 2024-09-24T02:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyra-therapeutics-gets-grant-for-sinus-scaffolds-for-treating-chronic-sinusitis/ 2024-09-24T02:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scpharmaceuticals-gets-grant-for-liquid-pharmaceutical-formulation-for-furosemide-treatment/ 2024-09-24T02:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkarta-gets-grant-for-genetically-engineered-nk-cells-targeting-cd70-for-immunotherapy/ 2024-09-24T02:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/assembly-biosciences-gets-grant-for-heteroaryl-carboxamide-compounds-for-treating-hepatitis-b/ 2024-09-24T02:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/starpharma-gets-grant-for-dendrimers-for-cancer-therapy-and-pharmaceutical-compositions/ 2024-09-24T02:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hikma-pharmaceuticals-gets-grant-for-ready-to-administer-hydromorphone-intravenous-liquid-formulation/ 2024-09-24T02:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcutis-biotherapeutics-gets-grant-for-topical-treatment-for-alopecia-areata-using-shr0302/ 2024-09-24T02:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocon-gets-grant-for-bispecific-chimeric-fusion-protein-for-cancer-therapy/ 2024-09-24T02:23:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regenxbio-gets-grant-for-cns-disorder-treatment-using-scaav9-vector-injection/ 2024-09-24T02:23:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/homology-medicines-gets-grant-for-aav-compositions-for-restoring-phenylalanine-hydroxylase-gene-function/ 2024-09-24T02:23:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melinta-therapeutics-gets-grant-for-treating-infections-in-obese-patients-with-delafloxacin/ 2024-09-24T02:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cipla-gets-grant-for-blister-strip-dispenser-with-waste-dose-collection-mechanism/ 2024-09-24T02:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stealth-biotherapeutics-gets-grant-for-aromatic-cationic-peptides-for-mitochondrial-targeted-antioxidant-therapy/ 2024-09-24T02:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mind-medicine-mindmed-gets-grant-for-lsd-orally-disintegrating-tablet-formulation-and-manufacturing-method/ 2024-09-24T02:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/23andme-holding-gets-grant-for-methods-for-constructing-and-displaying-genetic-pedigrees/ 2024-09-24T02:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ginkgo-bioworks-gets-grant-for-modified-aav-capsid-proteins-and-virus-vectors-for-administration/ 2024-09-24T02:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/theravance-biopharma-gets-grant-for-neprilysin-inhibiting-compounds-for-treating-related-diseases/ 2024-09-24T02:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bridgebio-pharma-gets-grant-for-treatment-methods-for-transthyretin-amyloidosis-attr-cardiomyopathy/ 2024-09-24T02:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shattuck-labs-gets-grant-for-chimeric-proteins-for-treating-tumors-and-inflammatory-diseases/ 2024-09-24T02:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otsuka-gets-grant-for-cancer-treatment-using-a-specific-compound/ 2024-09-24T02:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalent-gets-grant-for-activated-formylglycine-generating-enzymes-for-protein-production/ 2024-09-24T02:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alkermes-gets-grant-for-compounds-for-treating-narcolepsy-or-cataplexy/ 2024-09-24T02:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/halozyme-therapeutics-gets-grant-for-modified-ph20-hyaluronidase-polypeptides-with-enhanced-properties/ 2024-09-24T02:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/harrow-health-gets-grant-for-remote-eye-image-capture-and-data-anonymization-system/ 2024-09-24T02:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memorial-sloan-kettering-cancer-center-gets-grant-for-compounds-for-treating-protozoan-infections-and-related-diseases/ 2024-09-24T02:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-gets-grant-for-liquid-pharmaceutical-composition-for-oral-delivery-of-vigabatrin/ 2024-09-24T02:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-gets-grant-for-lsd1-inhibitor-compound-and-its-crystal-form/ 2024-09-24T02:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curevac-gets-grant-for-mrna-vaccine-for-prostate-cancer-treatment/ 2024-09-24T02:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boston-children-s-hospital-gets-grant-for-inhibiting-viral-envelope-region-to-treat-hiv-infections/ 2024-09-24T02:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amneal-pharmaceuticals-gets-grant-for-controlled-release-oral-formulation-of-levodopa/ 2024-09-24T02:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/veradigm-gets-grant-for-securing-prescription-data-on-a-computer-network/ 2024-09-24T02:23:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/children-s-medical-center-gets-grant-for-immunostimulatory-compositions-for-activating-dendritic-cell-responses/ 2024-09-24T02:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alector-gets-grant-for-antibodies-targeting-human-sirp-1-for-therapeutic-use/ 2024-09-24T02:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ayala-pharmaceuticals-gets-grant-for-pharmaceutical-salts-of-chemotherapeutic-drug-amino-acid-conjugates/ 2024-09-24T02:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-gets-grant-for-adenoviral-vector-with-regulatable-major-late-promoter/ 2024-09-24T02:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-gets-grant-for-method-for-treating-desmoid-tumors-with-nirogacestat/ 2024-09-24T02:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/community-health-systems-gets-grant-for-remote-sleep-diagnostic-system-with-biometric-identification/ 2024-09-24T02:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-cd73-inhibitors-for-treating-various-cancers/ 2024-09-24T02:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pliant-therapeutics-gets-grant-for-integrin-inhibitors-for-treating-fibrotic-diseases/ 2024-09-24T02:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcus-biosciences-gets-grant-for-hif-2a-inhibitors-for-treating-diseases-and-disorders/ 2024-09-24T02:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-crystalline-form-of-plinabulin-for-therapeutic-use/ 2024-09-24T02:22:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyenovia-gets-grant-for-ophthalmic-drug-delivery-using-a-charge-isolated-ejector-mechanism/ 2024-09-24T02:22:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-cancer-treatment-using-a2a-receptor-antagonists-and-pd-1-inhibitors/ 2024-09-24T02:22:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/betta-pharmaceuticals-gets-grant-for-crystal-form-of-a-specific-pharmaceutical-compound/ 2024-09-24T02:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crispr-therapeutics-gets-grant-for-gene-editing-for-angptl3-related-diseases-using-nanoparticles/ 2024-09-24T02:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-gets-grant-for-genome-editing-for-immuno-oncology-targeting-b2m-sequences/ 2024-09-24T02:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proqr-therapeutics-gets-grant-for-antisense-oligonucleotides-for-targeted-rna-editing/ 2024-09-24T02:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-templates-gets-grant-for-shiga-toxin-effector-polypeptides-for-targeted-therapeutics/ 2024-09-24T02:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocuphire-pharma-gets-grant-for-treatment-of-presbyopia-using-phentolamine-eye-drops/ 2024-09-24T02:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrowhead-pharmaceuticals-gets-grant-for-improved-linking-agents-for-oligonucleotide-attachment-and-delivery/ 2024-09-24T02:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-gets-grant-for-method-for-efficient-resin-supply-using-cartridge-replacement/ 2024-09-24T02:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-gets-grant-for-enzymatically-active-cas9-fusion-molecules-for-gene-editing/ 2024-09-24T02:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-gets-grant-for-method-for-preventing-cancer-metastasis-using-ibudilast/ 2024-09-24T02:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-gets-grant-for-cancer-treatment-using-anti-nkg2a-antibodies/ 2024-09-24T02:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/redhill-biopharma-gets-grant-for-method-for-preparing-monodisperse-oligo-ethylene-glycol-compositions/ 2024-09-24T02:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-gets-grant-for-variant-antibodies-with-improved-effector-functions/ 2024-09-24T02:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-cbl-b-inhibitors-for-immune-modulation-and-cancer-treatment/ 2024-09-24T02:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epivax-gets-grant-for-chimeric-polypeptides-with-immunoglobulin-fragments-and-active-molecules/ 2024-09-24T02:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kodiak-sciences-gets-grant-for-antagonistic-il-6-antibodies-fused-with-vegf-trap-proteins/ 2024-09-24T02:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/northwest-biotherapeutics-gets-grant-for-improved-cell-culture-systems-for-scalable-immunotherapeutic-manufacturing/ 2024-09-24T02:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunic-gets-grant-for-crystalline-polymorph-a-of-calcium-salt-compound/ 2024-09-24T02:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-gets-grant-for-motion-tracking-system-with-corrective-action-based-on-strap-stretch/ 2024-09-24T02:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kobayashi-pharmaceutical-gets-grant-for-interdental-cleaning-tool-with-triangular-shaft-and-deformable-cleaning-portion/ 2024-09-24T02:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-gets-grant-for-compounds-and-methods-for-pharmaceutical-compositions/ 2024-09-24T02:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/equillium-gets-grant-for-method-for-treating-alopecia-using-c-cytokine-antagonists/ 2024-09-24T02:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclerion-therapeutics-gets-grant-for-process-for-preparing-soluble-guanylate-cyclase-stimulators/ 2024-09-24T02:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-gets-grant-for-compounds-for-treating-diseases-and-pharmaceutical-compositions/ 2024-09-24T02:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-gets-grant-for-antibodies-for-neutralizing-hepatitis-b-and-d-viruses/ 2024-09-24T02:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-gets-grant-for-anti-trem1-antibodies-for-enhancing-immune-response-in-cancer/ 2024-09-24T02:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beam-therapeutics-gets-grant-for-nanoparticles-and-methods-for-their-use/ 2024-09-24T02:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c4-therapeutics-gets-grant-for-brd9-protein-degradation-compounds-for-treating-related-disorders/ 2024-09-24T02:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abcellera-biologics-gets-grant-for-transgenic-mammals-producing-canine-based-therapeutic-antibodies/ 2024-09-24T02:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-gets-grant-for-t-cell-modulatory-polypeptides-for-treating-type-1-diabetes/ 2024-09-24T02:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-gets-grant-for-machine-learning-methods-for-biological-perturbation-data-analysis/ 2024-09-24T02:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revolution-medicines-gets-grant-for-mtor-inhibitors-for-treating-various-cancers/ 2024-09-24T02:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biora-therapeutics-gets-grant-for-ingestible-device-for-locating-and-delivering-therapeutic-agents/ 2024-09-24T02:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-gets-grant-for-modulatory-polynucleotides-using-adeno-associated-virus-technology/ 2024-09-24T02:21:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-gets-grant-for-treatment-of-facioscapulohumeral-muscular-dystrophy-using-polynucleic-acids/ 2024-09-24T02:21:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldeyra-therapeutics-gets-grant-for-pharmaceutical-compositions-for-treating-various-diseases-and-conditions/ 2024-09-24T02:21:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mei-pharma-gets-grant-for-compounds-for-treating-proliferative-diseases/ 2024-09-24T02:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-gets-grant-for-estrogen-receptor-modulators-for-treating-related-diseases/ 2024-09-24T02:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-implantable-neuromodulation-system-optimizing-stimulation-via-blood-parameters/ 2024-09-24T02:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-gets-grant-for-methods-for-expanding-therapeutic-tumor-infiltrating-lymphocytes-tils/ 2024-09-24T02:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zevra-therapeutics-gets-grant-for-novel-prodrugs-and-compositions-of-dextrorphan/ 2024-09-24T02:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-gets-grant-for-asthma-exacerbation-probability-determination-system-and-method/ 2024-09-24T02:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spero-therapeutics-gets-grant-for-tebipenem-pivoxil-hbr-tablet-formulation-for-bacterial-infections/ 2024-09-24T02:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-gets-grant-for-liquid-pharmaceutical-composition-for-oral-delivery-of-vigabatrin/ 2024-09-24T02:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protagonist-therapeutics-gets-grant-for-pharmaceutical-compositions-for-treating-immune-system-disorders/ 2024-09-24T02:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celltrion-gets-grant-for-stable-liquid-formulation-of-anti-influenza-virus-antibodies/ 2024-09-24T02:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ardelyx-gets-grant-for-compounds-for-treating-fluid-retention-and-gastrointestinal-disorders/ 2024-09-24T02:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-gets-grant-for-pregabalin-lactam-methylene-dimer-and-its-preparation-method/ 2024-09-24T02:21:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/argenx-gets-grant-for-bispecific-antigen-binding-constructs-targeting-two-different-antigens/ 2024-09-24T02:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arbutus-biopharma-gets-grant-for-liver-targeting-sirna-conjugates-for-treating-hepatitis-diseases/ 2024-09-24T02:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zeria-pharmaceutical-gets-grant-for-antibody-binding-to-tumor-necrosis-factor-alpha-tnfa/ 2024-09-24T02:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-gets-grant-for-polynucleotides-encoding-cell-tags-for-immunotherapy-applications/ 2024-09-24T02:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-gets-grant-for-method-for-differentiating-stem-cells-into-retinal-ganglion-cells/ 2024-09-24T02:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-gets-grant-for-sustained-release-corticosteroid-compositions-for-pain-treatment/ 2024-09-24T02:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galderma-gets-grant-for-liposomal-compositions-for-skin-delivery-and-fat-reduction/ 2024-09-24T02:20:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/twist-bioscience-gets-grant-for-biomolecule-based-data-storage-and-synthesis-system/ 2024-09-24T02:20:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-gets-grant-for-compounds-for-treating-hepatitis-b-virus-infections/ 2024-09-24T02:20:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hu-group-gets-grant-for-method-for-measuring-lectin-binding-substances-in-samples/ 2024-09-24T02:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csl-gets-grant-for-antibody-proteins-targeting-human-granulocyte-colony-stimulating-factor-receptor/ 2024-09-24T02:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-gets-grant-for-method-for-preparing-deuterated-d-serine-analogs/ 2024-09-24T02:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-gets-grant-for-combination-therapy-for-cancer-treatment-using-glucocorticoids/ 2024-09-24T02:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-telepresence-network-management-system-for-healthcare-facilities/ 2024-09-24T02:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arvinas-gets-grant-for-bifunctional-compounds-for-targeting-and-degrading-lrrk2-protein/ 2024-09-24T02:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-gets-grant-for-method-for-producing-disease-specific-peptides-using-genomic-analysis/ 2024-09-24T02:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultragenyx-pharmaceutical-gets-grant-for-engineered-cell-lines-for-enhanced-raav-production/ 2024-09-24T02:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atyr-pharma-gets-grant-for-antibodies-targeting-human-neuropilin-2-for-therapeutic-use/ 2024-09-24T02:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-gets-grant-for-antibody-conjugates-targeting-folate-receptor-alpha-folr1/ 2024-09-24T02:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sosei-group-gets-grant-for-compounds-for-treating-muscarinic-receptor-mediated-diseases/ 2024-09-24T02:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-gets-grant-for-nucleic-acid-treatment-for-cardiovascular-disease-via-lpa-inhibition/ 2024-09-24T02:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eisai-gets-grant-for-therapeutic-agent-for-treating-fatty-liver-diseases/ 2024-09-24T02:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-gets-grant-for-treatment-of-gastrointestinal-stromal-tumors-using-compound-i/ 2024-09-24T02:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adverum-biotechnologies-gets-grant-for-modified-aav-capsid-for-enhanced-retinal-cell-targeting/ 2024-09-24T02:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/singular-genomics-systems-gets-grant-for-nucleic-acid-amplification-methods-using-circular-polynucleotides/ 2024-09-24T02:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-gets-grant-for-muscle-targeting-complexes-with-modified-oligonucleotides-for-therapy/ 2024-09-24T02:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeutic-solutions-international-gets-grant-for-method-for-reducing-lung-inflammation-using-stem-cells-and-t-regulatory-cells/ 2024-09-24T02:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pathai-gets-grant-for-predicting-patient-survival-time-using-pathology-images/ 2024-09-24T02:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-gets-grant-for-human-monoclonal-antibodies-targeting-4-1bb-for-cancer-treatment/ 2024-09-24T02:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allogene-therapeutics-gets-grant-for-constitutively-active-chimeric-cytokine-receptors-for-immune-cell-enhancement/ 2024-09-24T02:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-gets-grant-for-compounds-for-treating-autoimmune-diseases-and-inflammatory-conditions/ 2024-09-24T02:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-gets-grant-for-genetic-markers-for-clostridium-difficile-treatment-response/ 2024-09-24T02:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/praxis-precision-medicines-gets-grant-for-treatment-of-essential-tremor-using-specific-oral-dosage-forms/ 2024-09-24T02:20:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-gets-grant-for-system-for-industrial-growth-of-biologics/ 2024-09-24T02:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exelixis-gets-grant-for-crystalline-forms-of-c-met-inhibitor-compound-1/ 2024-09-24T02:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucb-gets-grant-for-gpr17-modulating-sulfonamide-compounds-for-treating-demyelination-disorders/ 2024-09-24T02:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evotec-gets-grant-for-inhibitors-of-epithelial-sodium-channel-for-treating-diseases/ 2024-09-24T02:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-gets-grant-for-double-stranded-oligonucleotide-for-inhibiting-amphiregulin-expression/ 2024-09-24T02:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biolinerx-gets-grant-for-oncolytic-virus-compositions-for-cancer-treatment-and-immunity/ 2024-09-24T02:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hanmi-science-gets-grant-for-obesity-treatment-using-a-novel-glucagon-derivative-peptide/ 2024-09-24T02:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-gets-grant-for-solid-phase-pharmaceutical-composition-with-specific-non-basic-excipients/ 2024-09-24T02:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codexis-gets-grant-for-engineered-amylase-polypeptides-with-improved-stability-properties/ 2024-09-24T02:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regeneron-pharmaceuticals-gets-grant-for-detecting-abnormal-karyotypes-using-sequencing-methods/ 2024-09-24T02:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cassava-sciences-gets-grant-for-pharmaceutical-composition-of-crystalline-and-amorphous-compounds/ 2024-09-24T02:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-gets-grant-for-liposome-compositions-for-sparingly-soluble-drug-delivery/ 2024-09-24T02:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-gets-grant-for-method-for-producing-infectious-paramyxovirus-particles-in-duck-cells/ 2024-09-24T02:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glenmark-pharmaceuticals-gets-grant-for-method-for-treating-allergic-rhinitis-with-mometasone-and-olopatadine/ 2024-09-24T02:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-gets-grant-for-neuroactive-steroids-for-sedation-and-anesthesia-treatment/ 2024-09-24T02:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-gets-grant-for-fluid-delivery-device-using-piezoelectric-actuator-for-dispensing/ 2024-09-24T02:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mallinckrodt-gets-grant-for-blood-processing-method-using-a-centrifuge-for-photopheresis/ 2024-09-24T02:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nektar-therapeutics-gets-grant-for-cancer-treatment-using-4-1bb-and-il-2r-agonists/ 2024-09-24T02:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mimedx-group-gets-grant-for-collagen-and-placental-tissue-compositions-for-wound-healing/ 2024-09-24T02:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daiichi-sankyo-gets-grant-for-monoclonal-antibody-for-treating-autoimmune-diseases/ 2024-09-24T02:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-gets-grant-for-orexin-type-2-receptor-agonist-for-narcolepsy-treatment/ 2024-09-24T02:19:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insmed-gets-grant-for-aerosolized-liposomal-amikacin-for-treating-lung-infections/ 2024-09-24T02:19:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-gets-grant-for-nucleases-for-cftr-gene-alteration-and-model-generation/ 2024-09-24T02:19:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytomx-therapeutics-gets-grant-for-polypeptides-with-cleavable-moieties-for-therapeutic-applications/ 2024-09-24T02:19:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-gets-grant-for-method-for-dosing-treatment-in-systemic-lupus-erythematosus/ 2024-09-24T02:19:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-gets-grant-for-cryoprotectant-for-treating-subcutaneous-lipid-rich-cells/ 2024-09-24T02:19:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-gets-grant-for-masp-2-inhibitory-compounds-and-their-uses/ 2024-09-24T02:19:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astrazeneca-gets-grant-for-antibody-molecules-targeting-egfr-and-c-met-for-cancer-treatment/ 2024-09-24T02:19:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galapagos-gets-grant-for-compounds-for-treating-various-inflammatory-and-proliferative-diseases/ 2024-09-24T02:19:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-gets-grant-for-fluid-injector-system-for-accurate-flow-rate-delivery/ 2024-09-24T02:19:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jcr-pharmaceuticals-gets-grant-for-fusion-antibody-for-treating-iduronate-2-sulfatase-deficiency/ 2024-09-24T02:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xoma-gets-grant-for-antibodies-targeting-transforming-growth-factor-beta-tgf/ 2024-09-24T02:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-gets-grant-for-cancer-treatment-using-compounds-that-inhibit-immune-checkpoints/ 2024-09-24T02:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/moderna-gets-grant-for-inducing-immune-response-against-hiv-using-mrna-compositions/ 2024-09-24T02:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nippon-shinyaku-gets-grant-for-antisense-oligomer-for-exon-skipping-in-dystrophin-gene/ 2024-09-24T02:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shionogi-gets-grant-for-minimally-colored-solid-pharmaceutical-preparation-with-light-stabilizers/ 2024-09-24T02:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-gets-grant-for-pharmaceutical-capsules-containing-lumateperone-for-oral-administration/ 2024-09-24T02:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xenon-pharmaceuticals-gets-grant-for-compounds-for-treating-seizure-disorders-like-epilepsy/ 2024-09-24T02:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grifols-gets-grant-for-treatment-of-muscle-degeneration-using-blood-plasma-fractions/ 2024-09-24T02:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-gets-grant-for-flow-analysis-method-for-moving-organ-using-4d-mr-data/ 2024-09-24T02:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-gets-grant-for-synthesis-method-for-n-protected-diketopiperazines/ 2024-09-24T02:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-gets-grant-for-device-for-isolating-platelet-rich-plasma-from-tissue-samples/ 2024-09-24T02:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipocine-gets-grant-for-oral-testosterone-undecanoate-compositions-for-replacement-therapy/ 2024-09-24T02:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chiesi-farmaceutici-gets-grant-for-modified-release-tablets-containing-deferiprone-for-oral-administration/ 2024-09-24T02:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-gets-grant-for-process-for-preparing-baricitinib-and-its-salts/ 2024-09-24T02:18:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amicus-therapeutics-gets-grant-for-migalastat-dosing-regimens-for-treating-fabry-disease-symptoms/ 2024-09-24T02:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-antibodies-binding-to-somatostatin-receptor-2-sstr2/ 2024-09-24T02:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-gets-grant-for-modular-synthetic-receptors-for-ligand-binding-and-activity-initiation/ 2024-09-24T02:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organovo-gets-grant-for-methods-for-fabricating-three-dimensional-biological-tissues-using-bioprinting/ 2024-09-24T02:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-pharmaceutical-gets-grant-for-inhibitors-of-autophagy-for-cancer-treatment/ 2024-09-24T02:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gc-gets-grant-for-novel-antibody-library-and-screening-method/ 2024-09-24T02:18:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cellectis-gets-grant-for-increased-dietary-fiber-in-hexaploid-triticum-plants/ 2024-09-24T02:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogen-gets-grant-for-assessing-pml-risk-in-multiple-sclerosis-patients/ 2024-09-24T02:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzo-biochem-gets-grant-for-methods-for-diagnosing-and-treating-viral-diseases/ 2024-09-24T02:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-gets-grant-for-rnai-agents-targeting-serpina1-gene-for-disease-treatment/ 2024-09-24T02:18:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascendis-pharma-gets-grant-for-long-acting-growth-hormone-treatment-for-deficiency-in-children/ 2024-09-24T02:18:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-gets-grant-for-crispr-method-for-modifying-cxcr4-gene-mutations/ 2024-09-24T02:18:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axsome-therapeutics-gets-grant-for-method-to-reduce-insomnia-risk-in-breastfed-infants/ 2024-09-24T02:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyepoint-pharmaceuticals-gets-grant-for-therapeutic-compounds-for-treating-eye-conditions-like-glaucoma/ 2024-09-24T02:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/santen-pharmaceutical-gets-grant-for-implantable-eye-device-with-fluid-flow-capabilities/ 2024-09-24T02:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merus-gets-grant-for-bispecific-igg-antibodies-targeting-clec12a-and-immune-cells/ 2024-12-11T09:06:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inovio-pharmaceuticals-gets-grant-for-nucleic-acid-molecules-encoding-synthetic-consensus-survivin-antigens/ 2024-09-24T02:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligand-pharmaceuticals-gets-grant-for-monoclonal-antibodies-targeting-human-4-1bb-for-cancer-treatment/ 2024-09-24T02:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-gets-grant-for-antibodies-targeting-and-antagonizing-tim-3-function/ 2024-09-24T02:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corcept-therapeutics-gets-grant-for-pyrimidinedione-compounds-as-glucocorticoid-receptor-modulators/ 2024-09-24T02:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ionis-pharmaceuticals-gets-grant-for-inhibiting-irf4-expression-to-treat-associated-cancers/ 2024-09-24T02:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocryst-pharmaceuticals-gets-grant-for-alk2-kinase-inhibitors-for-treating-fibrodysplasia-ossificans-progressiva/ 2024-09-24T02:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curis-gets-grant-for-cancer-treatment-using-compounds-that-inhibit-immune-checkpoints/ 2024-09-24T02:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astellas-pharma-gets-grant-for-stable-pharmaceutical-composition-with-antibody-fab-fragment-conjugate/ 2024-09-24T02:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pfizer-gets-grant-for-anti-cd47-antibodies-for-treating-cd47-expressing-cancers/ 2024-09-24T02:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanofi-gets-grant-for-rsv-polypeptides-for-antibody-elicitation-against-respiratory-syncytial-virus/ 2024-09-24T02:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipsen-gets-grant-for-stabilized-irinotecan-liposomes-with-reduced-lyso-pc-formation/ 2024-09-24T02:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viatris-gets-grant-for-topical-otic-ophthalmic-or-nasal-corticosteroid-suspension-formulation/ 2024-09-24T02:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bicycle-therapeutics-gets-grant-for-cd137-targeting-peptide-ligands-for-cancer-and-inflammation-treatment/ 2024-09-24T02:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-gets-grant-for-rip1-kinase-inhibitors-for-treating-associated-diseases/ 2024-09-24T02:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vertex-pharmaceuticals-gets-grant-for-immunomodulatory-proteins-with-variant-pd-1-polypeptides/ 2024-09-24T02:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-gets-grant-for-method-for-treating-glioma-with-specific-mutations/ 2024-09-24T02:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcturus-therapeutics-gets-grant-for-mrna-constructs-for-treating-cystic-fibrosis-via-inhalation/ 2024-09-24T02:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccinex-gets-grant-for-cancer-treatment-using-sema4d-targeting-antibodies-and-immune-therapy/ 2024-09-24T02:17:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biontech-gets-grant-for-rna-lipoplex-particles-for-targeted-delivery-and-storage/ 2024-09-24T02:17:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-johnson-gets-grant-for-surgical-instrument-for-harvesting-tendon-grafts/ 2024-09-24T02:17:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-gets-grant-for-thermal-energy-removal-system-for-specimen-sample-freezing/ 2024-09-24T02:17:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-gets-grant-for-gas-driven-drug-delivery-device-with-flexible-pushrod-assembly/ 2024-09-24T02:17:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunocore-gets-grant-for-t-cell-receptor-fusion-proteins-for-immune-targeting/ 2024-09-24T02:17:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-gains-exclusivity-rights-to-ventyxs-cns-penetrant-drug-in-27m-deal/ 2024-09-23T17:44:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pancreatic-cancer-the-clinical-trial-landscape-and-progress-for-2024/ 2025-01-23T15:21:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharmaceutical-compliance-management-software/ 2025-11-05T12:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/leading-pharmaceutical-logistics-supply-companies/ 2025-11-05T12:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsens-iqirvo-wins-european-approval-for-primary-biliary-cholangitis/ 2024-09-23T14:48:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/process-automation-equipment/ 2025-11-05T12:04:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-touts-safety-profile-of-once-monthly-schizophrenia-therapy/ 2024-09-23T14:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vicebio-secures-100m-to-advance-rsv-and-hmpv-vaccine-combo-to-phase-i/ 2024-09-23T14:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/leading-pharmaceutical-wholesalers/ 2025-11-05T12:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/cold-chain-storage-distribution/ 2025-11-05T12:05:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-msd-keytruda/ 2024-09-23T10:17:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-fruquintinib-mhra-approval/ 2024-09-23T10:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-flumist/ 2024-09-23T20:49:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zevra-miplyffa-fda-niemann-pick/ 2024-09-23T08:11:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-boom-set-to-revolutionise-healthcare-in-europe/ 2024-09-23T14:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gc-therapeutics-secures-65m-to-launch-into-off-the-shelf-ipsc-therapy-space/ 2024-09-20T16:43:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-eyes-approval-after-ms-therapy-slows-disease-progression-by-31/ 2024-09-25T09:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-approves-bavarian-nordics-mpox-vaccine-for-teenagers/ 2024-09-20T15:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-enhancing-therapy-adherence-with-prodrugs/ 2024-09-20T14:29:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/commercial-dose-companies/ 2025-11-05T12:05:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/commercial-dose-non-sterile-companies/ 2025-11-05T12:06:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/clinical-trials-development/ 2025-11-05T12:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/product-inspection-testing-detection-equipment-services/ 2025-11-05T12:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/packaging-machines-labelling/ 2025-11-05T12:10:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharmaceutical-consulting-companies/ 2025-11-05T12:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/freeze-drying-systems/ 2025-11-05T12:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/injectables/ 2025-11-05T12:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/protein-peptide-synthesis/ 2025-11-05T12:14:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharmaceutical-packaging-companies-2/ 2025-11-05T12:14:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharma-lab-equipment/ 2025-11-05T11:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharmaceutical-drug-delivery-market/ 2025-11-05T12:15:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/api-biologics-companies-contract-marketing/ 2025-11-05T12:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rxcell-cell-therapy-patent/ 2024-09-25T11:12:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-vanda-gastroparesis/ 2024-09-20T10:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-daiichi-sankyo-quizartinib-aml/ 2024-09-22T13:59:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-label-novo-nordisk-wegovy/ 2024-09-20T07:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biotechs-investigate-ways-to-adapt-to-new-clinical-trial-regulation-and-economic-flux/ 2024-09-23T14:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-and-nanovation-sign-600m-deal-in-rare-and-cardiometabolic-diseases/ 2024-09-25T11:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-fasenra-to-challenge-gsks-nucala-in-rare-vasculitis-after-fda-nod/ 2024-09-19T15:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cancer-therapies-for-young-adults-the-need-for-tailored-treatment-and-diversity/ 2024-10-23T15:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organon-makes-1-2bn-play-for-roivants-immuno-dermatology-subsidiary/ 2024-09-19T13:23:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lupin-takeda-vonoprazan-india/ 2024-09-19T10:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/accord-biopharma-hercessi-approval/ 2024-09-19T10:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/top-three-trends-in-precision-medicine/ 2024-09-19T08:39:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gavi-bavarian-nordic-mpox-vaccine/ 2024-09-19T08:15:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-msd-keytruda/ 2024-09-19T08:07:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leave-politics-out-of-healthcare-controversy-swirls-around-biosecure-act-2/ 2024-09-19T06:11:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-novartis-kisqali-label-to-include-early-breast-cancer-patients/ 2024-09-18T15:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-eyes-teenage-label-for-chikungunya-vaccine-in-europe-and-canada/ 2024-09-18T14:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ossium-treats-leukaemia-patient-with-cryopreserved-bone-marrow/ 2024-09-19T17:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-gsk-multiple-myeloma/ 2024-09-18T10:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orbis-vivtex-macrocycle-drugs/ 2024-09-18T09:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beigene-tevimbra-approval-israel/ 2024-09-18T08:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nura-bio-funding-neuroprotective-therapies/ 2024-09-18T08:03:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/express-scripts-sues-ftc-and-demands-drug-pricing-report-retraction/ 2024-09-17T16:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lifts-partial-clinical-hold-on-zentalis-pharmas-cancer-wee1-inhibitor/ 2024-09-17T16:04:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/equillium-collaborates-with-vivtex-for-oral-formulation-of-autoimmune-therapy/ 2024-09-17T15:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bicara-therapeutics-closes-362m-ipo-in-flurry-of-biotech-listing-activity/ 2024-09-17T12:59:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-how-drones-are-transforming-the-clinical-supply-chain-in-africa/ 2025-07-15T12:28:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-cuts-ties-immatics-bispecific-deal/ 2024-09-17T15:45:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rmat-poseida-car-t-bcma-allo1/ 2024-09-17T07:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maxcyte-kamau-therapeutics-strategic-platform-licence/ 2024-09-17T07:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-shipping-beyfortus-us/ 2024-09-17T07:25:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sbti-piramal-pharmas-ghg-targets/ 2024-09-17T07:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2024-keytruda-is-key-to-first-line-treatment-of-her2-mgej-adenocarcinoma/ 2024-09-18T21:56:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-seeks-approval-for-lung-fibrosis-drug-following-phase-iii-win/ 2024-09-16T15:32:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disease-modifiers-may-take-over-pah-landscape-says-cereno-ceo/ 2024-09-16T15:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-shelves-cabometyx-combo-in-prostate-cancer-after-phase-iii-miss/ 2024-09-16T13:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pioneering-epro-and-ecoa-innovations-for-next-generation-clinical-trials/ 2024-09-20T08:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-btd-blenrep-bordex-multiple-myeloma/ 2024-09-24T12:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-roche-ocrevus-zunovo/ 2024-09-16T10:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/after-the-lykos-debacle-whats-next-for-psychedelic-therapies/ 2024-09-17T12:50:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/minimizing-risks-in-pharmaceutical-supply-chains-what-you-need-to-know/ 2024-09-16T09:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-dupixent-crswnp/ 2024-09-16T08:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-ebglyss-fda-approval/ 2024-09-16T07:17:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2024-tigit-race-tightens-with-first-look-at-gsk-iteoss-tigit-in-nsclc/ 2024-09-16T01:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2024-enhertu-to-eclipse-soc-for-her2-breast-cancer-with-brain-metastases/ 2024-10-16T11:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-approves-updated-covid-19-vaccine-to-tackle-jn-1-variant/ 2024-09-13T17:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncternal-stock-crashes-by-60-as-it-lays-off-staff-and-scraps-trials/ 2024-09-13T16:12:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cidara-axes-30-of-staff-to-focus-on-flu-prevention-drug/ 2024-09-13T13:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-enable-injections-aspaveli/ 2024-09-13T10:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-roche-tecentriq-hybreza/ 2024-09-13T10:01:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/into-the-unknown-how-quickly-can-vaccines-be-developed-for-disease-x/ 2024-09-13T08:24:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-radioligand-therapy-deal/ 2024-09-13T08:19:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-invest-sites-ireland/ 2024-09-13T08:12:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-cuts-five-programmes-to-save-1-1bn-in-rd-costs/ 2024-09-12T15:53:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/easd-2024-innovent-shows-off-mazdutides-efficacy-in-diabetes-and-obesity/ 2024-09-12T15:37:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vermont-senator-introduces-bill-to-strengthen-340b-protections-for-drug-access/ 2024-09-12T15:34:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-promises-two-million-mpox-vaccines-for-africa-by-end-of-2024/ 2025-04-01T09:50:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agios-tebapivat-fda-designation/ 2024-09-12T10:26:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-suspends-entod-licence-drops/ 2024-09-12T10:14:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-btd-neuraptive-ntx-001/ 2024-09-12T07:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnsons-tremfya-fda-approval/ 2024-09-12T07:48:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2024-tetra-agonists-future-metabolic-diseases-treatment/ 2024-09-17T20:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iba-venture-pantera-gains-e134m-in-funding-to-scale-up-actinium-225-production/ 2024-09-11T15:04:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/easd2024-novo-nordisks-saxenda-shows-weight-loss-in-children/ 2024-09-11T13:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanosyrinx-biologic-therapeutics/ 2024-09-11T10:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-therapy-status-plozasiran/ 2024-09-11T10:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-inaugurates-vaccine-plant-france/ 2024-09-11T07:57:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-genesis-partner-therapies-ai/ 2024-09-11T07:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/prodrugs-and-patents-enhancing-therapy-adherence-and-reducing-side-effects/ 2024-09-11T20:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-agrees-to-pay-baltimore-city-80m-for-fuelling-opioid-epidemic/ 2024-09-10T19:29:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/easd2024-eli-lilly-releases-phase-iii-data-for-once-weekly-insulin-in-diabetes/ 2024-09-11T13:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-daiichis-adc-shows-better-survival-for-nonsquamous-nsclc-patients/ 2024-10-16T11:51:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/t-cell-targeting-candid-therapeutics-launches-with-370m/ 2024-09-10T16:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2024-novel-insights-into-maternal-protection-in-t1d/ 2024-09-10T14:04:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2024-new-developments-presymptomatic-type-1-diabetes-screening/ 2024-09-10T13:54:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-bill-chinese-biotech/ 2024-09-10T10:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/integrated-nanotherapeutics-secures-funds/ 2024-09-10T10:30:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vir-biotechnology-licence-deal-sanofi/ 2024-09-10T08:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-laval-facility-licence/ 2024-09-10T08:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cmn-005-coimmune-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-10T01:06:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-likelihood-of-approval/ 2024-09-10T01:06:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-nodal-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-10T01:06:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2024-09-10T01:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-10T01:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-10T01:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-b-cell-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-10T01:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-follicular-lymphoma-likelihood-of-approval/ 2024-09-10T01:04:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmn-005-coimmune-mantle-cell-lymphoma-likelihood-of-approval/ 2024-09-10T01:04:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sildenafil-citrate-xoma-royalty-female-hypoactive-sexual-desire-disorder-likelihood-of-approval/ 2024-09-10T01:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zaltenibart-omeros-paroxysmal-nocturnal-hemoglobinuria-likelihood-of-approval/ 2024-09-10T01:04:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zaltenibart-omeros-kidney-disease-nephropathy-likelihood-of-approval/ 2024-09-10T01:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zaltenibart-omeros-glomerulonephritis-likelihood-of-approval/ 2024-09-10T01:03:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bevacizumab-biosimilar-innovent-biologics-endometrial-cancer-likelihood-of-approval/ 2024-12-29T17:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-cutaneous-squamous-cell-carcinoma-cscc-likelihood-of-approval/ 2024-09-10T01:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cosibelimab-checkpoint-therapeutics-endometrial-cancer-likelihood-of-approval/ 2024-09-10T01:02:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/selpercatinib-loxo-oncology-sarcomas-likelihood-of-approval/ 2024-12-29T17:52:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cr-1301-conaris-research-institute-intestinal-infection-likelihood-of-approval/ 2024-09-10T01:01:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mcla-145-merus-merkel-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-angiosarcoma-likelihood-of-approval/ 2024-12-29T17:52:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemiplimab-regeneron-pharmaceuticals-acral-lentiginous-melanoma-likelihood-of-approval/ 2024-12-29T17:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amdizalisib-hutchison-medipharma-extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-likelihood-of-approval/ 2024-12-29T17:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amdizalisib-hutchison-medipharma-nodal-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:52:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-09-10T01:00:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-10T00:59:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-renal-cell-carcinoma-likelihood-of-approval/ 2024-09-10T00:59:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-solid-tumor-likelihood-of-approval/ 2024-09-10T00:59:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-liver-cancer-likelihood-of-approval/ 2024-09-10T00:59:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-09-10T00:58:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-ovarian-cancer-likelihood-of-approval/ 2024-09-10T00:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krls-004-kirilys-therapeutics-breast-cancer-likelihood-of-approval/ 2024-09-10T00:58:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergen-for-house-dust-mite-induced-allergic-rhinitis-and-rhinoconjunctivitis-hal-allergy-allergic-rhinitis-likelihood-of-approval/ 2024-09-10T00:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-1-proteinase-inhibitor-human-second-generation-kamada-pharmaceuticals-alpha-1-antitrypsin-deficiency-a1ad-likelihood-of-approval-3/ 2024-12-29T17:52:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/erfonrilimab-alphamab-oncology-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-12-29T17:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/alpha-1-proteinase-inhibitor-human-second-generation-kamada-pharmaceuticals-alpha-1-antitrypsin-deficiency-a1ad-likelihood-of-approval/ 2024-09-09T19:21:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mobocertinib-takeda-pharmaceutical-duodenal-cancer-likelihood-of-approval/ 2024-12-29T17:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/erfonrilimab-alphamab-oncology-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mobocertinib-takeda-pharmaceutical-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mobocertinib-takeda-pharmaceutical-sarcomas-likelihood-of-approval/ 2024-12-29T17:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-merkel-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:51:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mobocertinib-takeda-pharmaceutical-cervical-cancer-likelihood-of-approval/ 2024-12-29T17:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-papillary-thyroid-cancer-likelihood-of-approval/ 2024-12-29T17:51:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-12-29T17:51:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-neuroendocrine-tumors-likelihood-of-approval/ 2024-12-29T17:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-follicular-thyroid-cancer-likelihood-of-approval/ 2024-12-29T17:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-salivary-gland-cancer-likelihood-of-approval/ 2024-12-29T17:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-vulvar-cancer-likelihood-of-approval/ 2024-12-29T17:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:51:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-solid-tumor-likelihood-of-approval/ 2024-12-29T17:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-melanoma-likelihood-of-approval/ 2024-12-29T17:51:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-sepsis-likelihood-of-approval/ 2024-12-29T17:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:51:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envafolimab-alphamab-oncology-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamvac-vlp-adaptvac-malaria-likelihood-of-approval/ 2024-09-09T19:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sar-447537-sanofi-emphysema-likelihood-of-approval/ 2024-09-09T19:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/brepocitinib-tosylate-priovant-therapeutics-intermediate-uveitis-likelihood-of-approval/ 2024-12-29T17:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teriparatide-corium-osteoporosis-likelihood-of-approval/ 2024-09-09T19:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ritlecitinib-pfizer-celiac-disease-likelihood-of-approval/ 2024-12-29T17:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/brepocitinib-tosylate-priovant-therapeutics-posterior-uveitis-likelihood-of-approval/ 2024-12-29T17:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stem-cell-therapy-for-bone-degeneration-and-cartilage-degeneration-bioinova-cartilage-degeneration-likelihood-of-approval/ 2024-09-09T19:14:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rilparencel-prokidney-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-12-29T17:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg1-maraba-turnstone-biologics-breast-cancer-likelihood-of-approval/ 2024-09-09T19:14:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mg1-maraba-turnstone-biologics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T19:14:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/taletrectinib-adipate-nuvation-bio-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/human-adenovirus-type-5-recombinant-shanghai-sunway-biotech-malignant-ascites-likelihood-of-approval/ 2024-09-09T19:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/troriluzole-hydrochloride-biohaven-recurrent-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2024-12-29T17:50:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ue-2343-actinogen-medical-major-depressive-disorder-likelihood-of-approval/ 2024-12-29T17:50:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2024-12-29T17:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/troriluzole-hydrochloride-biohaven-gliosarcoma-likelihood-of-approval/ 2024-09-09T19:12:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-solid-tumor-likelihood-of-approval/ 2024-12-29T17:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-bile-duct-cancer-cholangiocarcinoma-likelihood-of-approval/ 2024-12-29T17:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-bladder-cancer-likelihood-of-approval/ 2024-12-29T17:50:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-metastatic-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-liver-cancer-likelihood-of-approval/ 2024-12-29T17:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-gastric-cancer-likelihood-of-approval/ 2024-12-29T17:50:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-prostate-cancer-likelihood-of-approval/ 2024-12-29T17:50:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-lung-cancer-likelihood-of-approval/ 2024-12-29T17:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexuzlimab-medannex-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cisplatin-vinblastine-sulphate-intensity-therapeutics-round-cell-liposarcoma-likelihood-of-approval/ 2024-12-29T17:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergen-for-pollen-grass-allergy-induced-allergic-rhinitis-and-rhinoconjunctivitis-hal-allergy-allergic-rhinitis-likelihood-of-approval/ 2024-09-09T19:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cisplatin-vinblastine-sulphate-intensity-therapeutics-dedifferentiated-liposarcoma-likelihood-of-approval/ 2024-12-29T17:49:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cisplatin-vinblastine-sulphate-intensity-therapeutics-myxoid-liposarcoma-likelihood-of-approval/ 2024-12-29T17:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chlorogenic-acid-sichuan-j-z-bio-chemical-science-and-technology-development-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cisplatin-vinblastine-sulphate-intensity-therapeutics-soft-tissue-sarcoma-likelihood-of-approval/ 2024-12-29T17:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/donafenib-tosylate-suzhou-zelgen-biopharmaceutical-endometrial-cancer-likelihood-of-approval/ 2024-09-09T19:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trilaciclib-g1-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-09-09T19:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aav-aqp1-meiragtx-sicca-syndrome-sjogren-likelihood-of-approval/ 2024-09-09T19:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dnp-002-dinona-solid-tumor-likelihood-of-approval/ 2024-12-29T17:49:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hynr-cs-allo-corestemchemon-spinocerebellar-ataxia-sca-likelihood-of-approval/ 2024-09-09T19:06:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hynr-cs-allo-corestemchemon-multiple-system-atrophy-msa-or-shy-drager-syndrome-or-multi-system-degeneration-likelihood-of-approval/ 2024-09-09T19:06:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rezafungin-acetate-napp-pharmaceuticals-pneumocystis-pneumonia-pneumocystosis-pneumocystis-jiroveci-pneumonia-likelihood-of-approval/ 2024-09-09T19:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hynr-cs-allo-corestemchemon-cerebellar-ataxia-likelihood-of-approval/ 2024-09-09T19:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-8189-merck-schizophrenia-likelihood-of-approval/ 2024-09-09T19:05:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rezafungin-acetate-napp-pharmaceuticals-aspergillosis-likelihood-of-approval/ 2024-12-29T17:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986258-bristol-myers-squibb-solid-tumor-likelihood-of-approval/ 2024-09-09T19:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eltrekibart-eli-lilly-and-co-hidradenitis-suppurativa-likelihood-of-approval/ 2024-12-29T17:49:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emavusertib-hydrochloride-curis-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T19:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emavusertib-hydrochloride-curis-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2024-09-09T19:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-oxybate-er-avadel-pharmaceuticals-type-2-narcolepsy-narcolepsy-without-cataplexy-likelihood-of-approval/ 2024-12-29T17:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-systemic-lupus-erythematosus-likelihood-of-approval/ 2024-12-29T17:49:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amlitelimab-sanofi-alopecia-areata-likelihood-of-approval/ 2024-12-29T17:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-oxybate-er-avadel-pharmaceuticals-type-1-narcolepsy-narcolepsy-with-cataplexy-likelihood-of-approval/ 2024-12-29T17:49:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gene-therapy-for-gd2-expressing-solid-tumors-bellicum-pharmaceuticals-high-grade-glioma-likelihood-of-approval/ 2024-09-09T19:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gene-therapy-for-gd2-expressing-solid-tumors-bellicum-pharmaceuticals-pediatric-diffuse-intrinsic-pontine-glioma-likelihood-of-approval/ 2024-09-09T19:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iscalimab-novartis-lupus-nephritis-likelihood-of-approval/ 2024-12-29T17:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gene-therapy-for-gd2-expressing-solid-tumors-bellicum-pharmaceuticals-medulloblastoma-likelihood-of-approval/ 2024-09-09T19:01:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fenretinide-laurent-pharmaceuticals-cystic-fibrosis-likelihood-of-approval/ 2024-12-29T17:48:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iscalimab-novartis-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/ 2024-12-29T17:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/utidelone-biostar-pharmaceuticals-testicular-cancer-likelihood-of-approval/ 2024-12-29T17:48:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/utidelone-biostar-pharmaceuticals-fallopian-tube-cancer-likelihood-of-approval/ 2024-12-29T17:48:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccine-for-central-nervous-system-cancer-immunomic-therapeutics-oligodendroglioma-likelihood-of-approval/ 2024-09-09T19:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cc-90002-bristol-myers-squibb-solid-tumor-likelihood-of-approval/ 2024-09-09T19:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/futibatinib-otsuka-pharmaceutical-endometrial-cancer-likelihood-of-approval/ 2024-12-29T17:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccine-for-central-nervous-system-cancer-immunomic-therapeutics-anaplastic-astrocytoma-likelihood-of-approval/ 2024-09-09T18:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tislelizumab-beigene-gallbladder-cancer-likelihood-of-approval/ 2024-09-09T18:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molgramostim-savara-lung-disease-likelihood-of-approval/ 2024-12-29T17:48:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zanubrutinib-beigene-extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-likelihood-of-approval/ 2024-12-29T17:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zanubrutinib-beigene-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medi-1814-astrazeneca-alzheimer-s-disease-likelihood-of-approval/ 2024-09-09T18:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zanubrutinib-beigene-nodal-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-12-29T17:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acalabrutinib-maleate-astrazeneca-extranodal-marginal-zone-b-cell-lymphoma-mucosa-associated-lymphoid-tissue-or-malt-lymphoma-likelihood-of-approval/ 2024-09-09T18:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acalabrutinib-maleate-astrazeneca-splenic-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T18:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pneumococcal-vaccine-cansino-biologics-streptococcal-pneumonia-likelihood-of-approval/ 2024-12-29T17:48:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acalabrutinib-maleate-astrazeneca-nodal-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-09-09T18:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/byon-4413-byondis-refractory-acute-myeloid-leukemia-likelihood-of-approval/ 2024-12-29T17:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/byon-4413-byondis-relapsed-acute-myeloid-leukemia-likelihood-of-approval/ 2024-12-29T17:48:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/furestem-cd-kangstem-biotech-crohn-s-disease-regional-enteritis-likelihood-of-approval/ 2024-09-09T18:55:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/byon-4413-byondis-myelodysplastic-syndrome-likelihood-of-approval/ 2024-12-29T17:48:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamiparib-beigene-peritoneal-cancer-likelihood-of-approval/ 2024-12-29T17:48:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sefaxersen-sodium-f-hoffmann-la-roche-geographic-atrophy-likelihood-of-approval/ 2024-09-09T18:55:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamiparib-beigene-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-12-29T17:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamiparib-beigene-fallopian-tube-cancer-likelihood-of-approval/ 2024-12-29T17:48:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamiparib-beigene-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:47:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pamiparib-beigene-endometrial-cancer-likelihood-of-approval/ 2024-12-29T17:47:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-101-alector-mild-cognitive-impairment-likelihood-of-approval/ 2024-09-09T18:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-101-alector-dementia-associated-with-alzheimer-s-disease-likelihood-of-approval/ 2024-09-09T18:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/larotrectinib-sulfate-bayer-sarcomas-likelihood-of-approval/ 2024-12-29T17:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/entrectinib-f-hoffmann-la-roche-metastatic-pancreatic-cancer-likelihood-of-approval/ 2024-12-29T17:47:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sx-682-syntrix-pharmaceuticals-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-12-29T17:47:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sx-682-syntrix-pharmaceuticals-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-12-29T17:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sx-682-syntrix-pharmaceuticals-oropharyngeal-cancer-likelihood-of-approval/ 2024-12-29T17:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sx-682-syntrix-pharmaceuticals-recurrent-head-and-neck-squamous-cell-carcinoma-likelihood-of-approval/ 2024-12-29T17:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T18:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-09-09T18:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-solid-tumor-likelihood-of-approval/ 2024-09-09T18:50:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-endometrial-cancer-likelihood-of-approval/ 2024-09-09T18:50:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-gastric-cancer-likelihood-of-approval/ 2024-09-09T18:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-bladder-cancer-likelihood-of-approval/ 2024-09-09T18:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ceralasertib-astrazeneca-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oberotatug-ravtansine-oxford-biotherapeutics-ovarian-cancer-likelihood-of-approval/ 2024-09-09T18:49:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anti-viral-central-memory-cd8-veto-cells-cell-source-sickle-cell-disease-likelihood-of-approval/ 2024-12-29T17:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afabicin-debiopharm-international-osteomyelitis-likelihood-of-approval/ 2024-09-09T18:49:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-recurrent-glioblastoma-multiforme-gbm-likelihood-of-approval/ 2024-12-29T17:47:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elraglusib-actuate-therapeutics-neuroblastoma-likelihood-of-approval/ 2024-12-29T17:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-high-grade-glioma-likelihood-of-approval/ 2024-12-29T17:47:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-anaplastic-oligoastrocytoma-likelihood-of-approval/ 2024-12-29T17:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-oligodendroglioma-likelihood-of-approval/ 2024-12-29T17:47:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-gliosarcoma-likelihood-of-approval/ 2024-09-09T18:47:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/citarinostat-bristol-myers-squibb-solid-tumor-likelihood-of-approval/ 2024-12-29T17:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cld-101-calidi-biotherapeutics-anaplastic-astrocytoma-likelihood-of-approval/ 2024-12-29T17:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nemvaleukin-alfa-mural-oncology-metastatic-breast-cancer-likelihood-of-approval/ 2024-09-09T18:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/citarinostat-bristol-myers-squibb-multiple-myeloma-kahler-disease-likelihood-of-approval/ 2024-12-29T17:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caly-002-novartis-celiac-disease-likelihood-of-approval/ 2024-12-29T17:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caly-002-novartis-eosinophilic-esophagitis-likelihood-of-approval/ 2024-12-29T17:46:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-duocarmazine-byondis-metastatic-breast-cancer-likelihood-of-approval/ 2024-12-29T17:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iadademstat-oryzon-genomics-acute-myelocytic-leukemia-aml-acute-myeloblastic-leukemia-likelihood-of-approval/ 2024-09-09T18:44:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/volixibat-potassium-mirum-pharmaceuticals-primary-sclerosing-cholangitis-likelihood-of-approval/ 2024-12-29T17:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trastuzumab-duocarmazine-byondis-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syd-3521-byondis-endometrial-cancer-likelihood-of-approval/ 2024-09-09T18:43:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/volixibat-potassium-mirum-pharmaceuticals-primary-biliary-cholangitis-primary-biliary-cirrhosis-likelihood-of-approval/ 2024-12-29T17:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syd-3521-byondis-ovarian-cancer-likelihood-of-approval/ 2024-09-09T18:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syd-3521-byondis-cervical-cancer-likelihood-of-approval/ 2024-09-09T18:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adct-701-adc-therapeutics-neuroendocrine-carcinoma-likelihood-of-approval/ 2024-09-09T18:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adct-701-adc-therapeutics-adrenocortical-carcinoma-adrenal-cortex-cancer-likelihood-of-approval/ 2024-09-09T18:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-588410-shionogi-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T18:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/efgartigimod-alfa-argenx-bullous-pemphigoid-likelihood-of-approval/ 2024-12-29T17:46:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endoxifen-jina-pharmaceuticals-bipolar-i-disorder-likelihood-of-approval/ 2024-12-29T17:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rebonuputemcel-discgenics-degenerative-disc-disease-likelihood-of-approval/ 2024-12-29T17:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aminolevulinic-acid-hydrochloride-photonamic-ovarian-cancer-likelihood-of-approval/ 2024-12-29T17:46:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aminolevulinic-acid-hydrochloride-photonamic-colorectal-cancer-likelihood-of-approval/ 2024-12-29T17:46:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avelumab-merck-angiosarcoma-likelihood-of-approval/ 2024-12-29T17:46:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulotaront-hydrochloride-otsuka-pharmaceutical-generalized-anxiety-disorder-gad-likelihood-of-approval/ 2024-09-09T18:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/capsulin-oad-diabetology-products-type-2-diabetes-likelihood-of-approval/ 2024-09-09T18:39:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avelumab-merck-cervical-cancer-likelihood-of-approval/ 2024-12-29T17:46:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jm-010-contera-pharma-dyskinesia-likelihood-of-approval/ 2024-09-09T18:39:06+00:00 daily 0.2